Henry Schein, Inc. HSIC
84.80 USD -0.89 (-1.04%)
Regular-session close
84.80 0.00 0.00%
After hours · Nov 19, 4:00 PM ET
83.40 Day range 85.12
68.70 52-week range 92.18
- YTD
- +12.20%
- 1 year
- +20.11%
News
seekingalpha.com Henry Schein, Inc. (HSIC) Presents at Jefferies Global Healthcare Conference 2026 Transcript Henry Schein, Inc. (HSIC) Presents at Jefferies Global Healthcare Conference 2026 Transcriptbenzinga.com Morgan Stanley Maintains Underweight on Henry Schein, Raises Price Target to $68 Morgan Stanley analyst Erin Wright maintains Henry Schein (NASDAQ:HSIC) with a Underweight and raises the price target from $64 to $68.
benzinga.com Henry Schein To Exclude Gains Resulting From Remeasurement To Fair Value Of Previously Held Equity Interests From Its Non-GAAP Financial Results; Updates FY26 Adjusted EPS Guidance To $5.42-$5.48 To Reflect The Change Updates FY26 total sales growth to 4.5%-5.5% yoyAs a result of the announced change in the Company’s presentation of non-GAAP financial measures, Henry Schein is updating its FY2026 non-GAAP diluted…
businesswire.com Henry Schein Updates Presentation of Non-GAAP Financial Measures MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced an update…benzinga.com UBS Maintains Neutral on Henry Schein, Raises Price Target to $95 UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises the price target from $94 to $95.
benzinga.com Evercore ISI Group Maintains Outperform on Henry Schein, Lowers Price Target to $100 Evercore ISI Group analyst Elizabeth Anderson maintains Henry Schein (NASDAQ:HSIC) with a Outperform and lowers the price target from $105 to $100.
benzinga.com Henry Schein Sees Pressure From Discretionary Dental Delays Henry Schein drops after Q3 results: an EPS beat and raised 2026 guidance are offset by softness in discretionary dental procedures.
benzinga.com Henry Schein Q3 2026 Earnings Call Transcript Henry Schein (NASDAQ:HSIC) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…benzinga.com Henry Schein Raises FY2026 Adj EPS Guidance from $5.29-$5.39 to $5.50-$5.56 vs $5.39 Est; Affirms FY2026 Sales Guidance of $13.794B-$13.926B vs $13.866B Est Henry Schein (NASDAQ:HSIC) raises FY2026 Adj EPS guidance from $5.29-$5.39 to $5.50-$5.56 vs $5.39 analyst estimate. Affirms FY2026 sales outlook from $13.794 billion-$13.926 billion to $13.794…
benzinga.com Henry Schein Q3 Adj. EPS $1.56 Beats $1.36 Estimate, Sales $3.471B Miss $3.476B Estimate Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $1.56 per share which beat the analyst consensus estimate of $1.36 by 14.71 percent. This is a 13.04 percent increase over earnings of $1.38…
247wallst.com Henry Schein Inc Looking ahead to 2030, our model projects HSIC could trade at an average price of $159.27, with a potential range between $119.45 and $199.09. This represents a potential 84.7% return from today’s ...
finance.sina.com.cn 亨利香恩服务收涨3.32%,成交额1.77亿美元 11月19日,亨利香恩服务(HSIC)收涨3.32%,报85.69美元,成交额1.77亿美元,市值94.72亿美元。 公司最新财报显示,季度营收34.71亿美元,同比增长3.95%;净利润1.19亿美元,同比增长17.82%。 公司简介…
tradersunion.com What's behind Henry Schein's latest 3.5% stock surge? Henry schein rises 3.49% today to $85.78 after operational update, with technicals showing bullish strength and renewed ...
finance.yahoo.com Henry Schein (HSIC) Stock May Be Undervalued After EPS Guidance Reset Henry Schein has delivered a steady 3 year gain for shareholders, yet its latest guidance reset and accounting tweaks put a ...
finance.yahoo.com Cleaner Earnings Guidance Could Be Material For Henry Schein Stock (HSIC) Henry Schein updated its fiscal 2026 non-GAAP diluted EPS guidance after deciding to exclude acquisition-related ...
theglobeandmail.com Analysts Offer Insights on Healthcare Companies: Incyte (INCY) and Henry Schein (HSIC) Analysts have been eager to weigh in on the Healthcare sector with new ratings on Incyte and Henry Schein . Incyte (INCY) In a report released today, Mitchell Kapoor from H.C. Wai ...
